SCHEMBL21285605

SCHEMBL21285605

Cc1ccccc1N1CCN(c2ccc3ccn(CCN4CCC(C)(C)C4)c3n2)CC1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ADRA1B P35368 3/20 0.38
▸ HTR1A P08908 2/20 0.38
▸ PARP1 P09874 1/20 0.36
▸ ADRA1A P35348 4/20 0.36
▸ ADRA1D P25100 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HTR7 P34969 2/20 0.35
▸ ATM Q13315 1/20 0.34
▸ DRD2 P14416 2/20 0.34
▸ DRD3 P35462 2/20 0.34
▸ AKR1C3 P42330 1/20 0.34
▸ BCHE P06276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21274397 0.90 HTR1A (0.37) ADRA1BHTR1APARP1ADRA1AADRA1D
SCHEMBL21281500 0.85 ADRA1A (0.45) ADRA1BHTR1APARP1ADRA1AADRA1D
SCHEMBL21273954 0.84 PARP1 (0.45) ADRA1BHTR1APARP1ADRA1AADRA1D
Ammonia Solution, Strong SCHEMBL28505508 0.81 ADRA1B (0.35) ADRA1BHTR1APARP1ADRA1AADRA1D
SCHEMBL21268787 0.81 PARP1 (0.42) ADRA1BHTR1APARP1ADRA1AADRA1D
SCHEMBL21285495 0.81 PARP1 (0.42) ADRA1BPARP1ADRA1AADRA1DALDH1A1
SCHEMBL21274394 0.80 NPC1 (0.37) ADRA1BHTR1APARP1ADRA1AADRA1D
Formamide SCHEMBL21274109 0.79 PARP1 (0.36) ADRA1BHTR1APARP1ADRA1AADRA1D
SCHEMBL21273937 0.78 ADRA1A (0.37) ADRA1BHTR1APARP1ADRA1AADRA1D
SCHEMBL21281469 0.78 DRD2 (0.39) ADRA1BPARP1ADRA1AADRA1DDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019158731-A1 PHARMACEUTICAL 6,5 HETEROBICYCLIC RING DERIVATIVES UCB BIOPHARMA SPRL (BE) 2019-08-22 — — WO disclosed
Send feedback